| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.755 | 1.737 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.032 |
| Total Income - EUR | 1.755 | 1.737 | 0 | 0 | 0 | 0 | 107 | 144 | 7 | 22.166 |
| Total Expenses - EUR | 25 | 6 | 0 | 0 | 0 | 0 | 47.068 | 93.117 | 73.367 | 99.461 |
| Gross Profit/Loss - EUR | 1.730 | 1.731 | 0 | 0 | 0 | 0 | -46.962 | -92.973 | -73.360 | -77.294 |
| Net Profit/Loss - EUR | 1.677 | 1.679 | 0 | 0 | 0 | 0 | -46.965 | -92.973 | -73.360 | -77.294 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bio Pharma System S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 7.503 | 28.272 | 31.357 | 35.954 |
| Current Assets | 1.775 | 3.413 | 3.326 | 3.265 | 3.202 | 3.141 | 49.758 | 56.100 | 63.943 | 96.482 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 26.446 | 38.310 | 41.430 | 65.429 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 7.972 | 14.979 | 21.906 | 29.271 |
| Cash | 1.775 | 3.413 | 3.326 | 3.265 | 3.202 | 3.141 | 15.340 | 2.811 | 607 | 1.782 |
| Shareholders Funds | 1.722 | 3.383 | 3.326 | 3.265 | 3.202 | 3.141 | -43.893 | -137.002 | -209.946 | -286.067 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 53 | 30 | 0 | 0 | 0 | 0 | 101.155 | 221.374 | 305.246 | 418.503 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1086 - 1086" | |||||||||
| CAEN Financial Year |
1086
|
|||||||||
Comments - Bio Pharma System S.r.l.